Shandong Weigao executes share repurchase, boosts treasury holdings

Shandong Weigao Group Medical Polymer Company Limited, an equity issuer listed on the exchange, disclosed a share repurchase on November 24, 2025. The company repurchased 40,000 H shares on the exchange at a price of HK$5.29 per share, totaling an aggregate cost of HK$211,600. These repurchased shares are being held as treasury shares.

Following this transaction, the number of issued shares (excluding treasury shares) decreased by 40,000 to 4,495,909,524, representing a 0.0009% change from the previous balance. Concurrently, the number of treasury shares increased by 40,000 to 26,422,800. The total number of issued shares remains unchanged at 4,522,332,324.

The company's repurchase mandate, granted on May 27, 2025, authorized the repurchase of up to 451,560,392 shares. With the latest repurchase, Shandong Weigao has repurchased a total of 19,774,400 shares on the exchange, representing 4.3791% of its issued shares (excluding treasury shares) as of the mandate date. A moratorium on new share issues or treasury share sales is in effect until December 23, 2025.